255 related articles for article (PubMed ID: 25278094)
1. Alisol B 23-acetate promotes liver regeneration in mice after partial hepatectomy via activating farnesoid X receptor.
Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Peng J; Liu K
Biochem Pharmacol; 2014 Nov; 92(2):289-98. PubMed ID: 25278094
[TBL] [Abstract][Full Text] [Related]
2. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of alisol B 23-acetate from edible botanical Rhizoma alismatis against carbon tetrachloride-induced hepatotoxicity in mice.
Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Liu K
Food Funct; 2015 Apr; 6(4):1241-50. PubMed ID: 25747392
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
[TBL] [Abstract][Full Text] [Related]
5. Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.
Meng Q; Duan XP; Wang CY; Liu ZH; Sun PY; Huo XK; Sun HJ; Peng JY; Liu KX
Acta Pharmacol Sin; 2017 Jan; 38(1):69-79. PubMed ID: 27773935
[TBL] [Abstract][Full Text] [Related]
6. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
[TBL] [Abstract][Full Text] [Related]
7. Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis.
Fu Y; Feng H; Ding X; Meng QH; Zhang SR; Li J; Chao Y; Ji TT; Bi YH; Zhang WW; Chen Q; Zhang YH; Feng YL; Bian HM
Phytomedicine; 2022 Jul; 101():154120. PubMed ID: 35523117
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription.
Chen WD; Wang YD; Zhang L; Shiah S; Wang M; Yang F; Yu D; Forman BM; Huang W
Hepatology; 2010 Mar; 51(3):953-62. PubMed ID: 19998409
[TBL] [Abstract][Full Text] [Related]
9. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.
Ding L; Yang Y; Qu Y; Yang T; Wang K; Liu W; Xia W
Mol Med Rep; 2015 Jun; 11(6):4431-7. PubMed ID: 25634785
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice.
Borude P; Edwards G; Walesky C; Li F; Ma X; Kong B; Guo GL; Apte U
Hepatology; 2012 Dec; 56(6):2344-52. PubMed ID: 22730081
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
12. The role of bile salts in liver regeneration.
van de Laarschot LF; Jansen PL; Schaap FG; Olde Damink SW
Hepatol Int; 2016 Sep; 10(5):733-40. PubMed ID: 27048617
[TBL] [Abstract][Full Text] [Related]
13. A naturally occurring FXR agonist, alisol B 23-acetate, protects against renal ischemia-reperfusion injury.
Luan ZL; Ming WH; Sun XW; Zhang C; Zhou Y; Zheng F; Yang YL; Guan YF; Zhang XY
Am J Physiol Renal Physiol; 2021 Nov; 321(5):F617-F628. PubMed ID: 34569253
[TBL] [Abstract][Full Text] [Related]
14. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.
Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T
Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672
[TBL] [Abstract][Full Text] [Related]
15. Insufficient bile acid signaling impairs liver repair in CYP27(-/-) mice.
Meng Z; Liu N; Fu X; Wang X; Wang YD; Chen WD; Zhang L; Forman BM; Huang W
J Hepatol; 2011 Oct; 55(4):885-95. PubMed ID: 21334403
[TBL] [Abstract][Full Text] [Related]
16. Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury.
Gao X; Fu T; Wang C; Ning C; Kong Y; Liu Z; Sun H; Ma X; Liu K; Meng Q
Biochem Pharmacol; 2017 Dec; 146():127-138. PubMed ID: 28987596
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled metabolic reprogramming.
Xie Y; Wang H; Cheng X; Wu Y; Cao L; Wu M; Xie W; Wang G; Hao H
Sci Rep; 2016 Jan; 6():18751. PubMed ID: 26728993
[TBL] [Abstract][Full Text] [Related]
18. Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes.
Vacca M; Murzilli S; Salvatore L; Di Tullio G; D'Orazio A; Lo Sasso G; Graziano G; Pinzani M; Chieppa M; Mariani-Costantini R; Palasciano G; Moschetta A
Gastroenterology; 2013 Jun; 144(7):1518-1529.e3. PubMed ID: 23462179
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity.
Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q
Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579
[TBL] [Abstract][Full Text] [Related]
20. Carbamazepine promotes liver regeneration and survival in mice.
Kawaguchi T; Kodama T; Hikita H; Tanaka S; Shigekawa M; Nawa T; Shimizu S; Li W; Miyagi T; Hiramatsu N; Tatsumi T; Takehara T
J Hepatol; 2013 Dec; 59(6):1239-45. PubMed ID: 23872603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
